Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01129284
What this trial is testing

Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)

Who this might be right for
Treatment Resistant Nephrotic Syndrome
Columbia University 15
Not applicableStudy completedNCT04108611
What this trial is testing

Immune Adsorption Role in Treatment of Resistant Lupus

Who this might be right for
Systemic Lupus
Dr. Mohamed Ahmed El ghiriani 90
Testing effectiveness (Phase 2)Looking for participantsNCT07614477
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases

Who this might be right for
Minimal Change Disease (MCD)IgA Nephropathy (IgAN)Focal Segmental Glomerulosclerosis (FSGS)
Everest Medicines (China) Co.,Ltd. 45
Not applicableUnknownNCT04894695
What this trial is testing

Urine Exosomes to Identify Biomarkers for LN

Who this might be right for
Lupus Nephritis
RenJi Hospital 400
Testing effectiveness (Phase 2)Study completedNCT00709722
What this trial is testing

Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Nippon Kayaku Co., Ltd. 21
Post-approval studies (Phase 4)Study completedNCT00125307
What this trial is testing

Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis

Who this might be right for
Lupus NephritisLupus Erythematosus, Systemic
Chinese University of Hong Kong 20
Not applicableNot Yet RecruitingNCT06315504
What this trial is testing

Circulating Factors in Nephrotic Syndrome

Who this might be right for
Nephrotic SyndromeMembranous NephropathyMinimal Change Disease+1 more
Iain Bressendorff 104
Testing effectiveness (Phase 2)Looking for participantsNCT03949855
What this trial is testing

Belimumab With Rituximab for Primary Membranous Nephropathy

Who this might be right for
Membranous NephropathyNephrotic Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 58
Testing effectiveness (Phase 2)Study completedNCT06717815
What this trial is testing

Phase IIa Study for IPG11406 in Patients With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Nanjing Immunophage Biotech Co., Ltd 24
Post-approval studies (Phase 4)Study completedNCT04146220
What this trial is testing

Efficacy of Lower Dose Prednisolone in the Induction of Remission of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 32
Testing effectiveness (Phase 2)Looking for participantsNCT07363460
What this trial is testing

Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN

Who this might be right for
Lupus Nephritis (LN)
Haisco Pharmaceutical Group Co., Ltd. 105
Large-scale testing (Phase 3)Active Not RecruitingNCT05914155
What this trial is testing

Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy With Nephrotic Syndrome

Who this might be right for
Glomerulonephritis, MembranousNephrotic Syndrome，Idiopathic
Shoichi Maruyama MD PhD 88
Very early researchNot Yet RecruitingNCT07674147
What this trial is testing

RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases

Who this might be right for
Autoimmune DiseasesSLE - Systemic Lupus ErythematosusSSc-Systemic Sclerosis+3 more
The Children's Hospital of Zhejiang University School of Medicine 30
Not applicableLooking for participantsNCT07295808
What this trial is testing

Identification and Characterisation of IgA With Nephritogenic Potential in IgA Deposition Nephropathies (Rep-IgAN)

Who this might be right for
Kidney Disease
University Hospital, Limoges 150
Testing effectiveness (Phase 2)Ended earlyNCT00424749
What this trial is testing

Rituxan in Churg Strauss Syndrome With Renal Involvement

Who this might be right for
Churg-Strauss Syndrome
Fernando Fervenza 4
Not applicableStudy completedNCT03921398
What this trial is testing

Identifying New Therapeutic Targets for Lupus Treatment

Who this might be right for
Lupus Nephritis
Assistance Publique - Hôpitaux de Paris 87
Not applicableUnknownNCT05656963
What this trial is testing

The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKD

Who this might be right for
Glomerulonephritis, MembranousDiabetic NephropathiesThrombelastography+1 more
Yipeng Liu 741
Not applicableUnknownNCT04534647
What this trial is testing

Serological and Urinary Biomarkers in Latin American Patients With Systemic Lupus Erythematosus: GLADEL 2.0 Cohort

Who this might be right for
Lupus Nephritis
Liga Panamericana de Asociaciones de Reumatologia (PANLAR) 100
Not applicableNot Yet RecruitingNCT07598448
What this trial is testing

Complement 3 Glomerulopathy (C3G) Patients Treated With Iptacopan Through an Early Access Program in Spain

Who this might be right for
Complement 3 Glomerulopathy
Novartis Pharmaceuticals 35
Testing effectiveness (Phase 2)Looking for participantsNCT03673748
What this trial is testing

Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells

Who this might be right for
Lupus NephritisLupus Erythematosus
Red de Terapia Celular 20
Next Page